- Service Name
Alkermes
- Industry
Biopharmaceutical, healthcare, neuroscience, psychiatric and neurological disorders
- Main Value Proposition
Alkermes offers innovative treatment options for patients with complex and difficult-to-treat psychiatric and neurological disorders, aiming to improve their quality of life.
- Description
Alkermes is a global biopharmaceutical company focused on developing innovative medicines for complex psychiatric and neurological disorders. The company leverages its expertise in neuroscience to create impactful treatment options for patients.
- Key Features
Innovative medicines for psychiatric and neurological disorders; Strong focus on research and development in neuroscience; Commitment to corporate responsibility and patient advocacy; Recognition as an employer of choice in the life sciences industry
- Use Cases
Alkermes' medicines are most valuable for patients suffering from schizophrenia, bipolar disorder, narcolepsy, and other complex neurological conditions.
- Competitive advantages
Strong pipeline of investigational drugs targeting complex disorders; Established reputation in the life sciences industry as an employer of choice; Focus on corporate responsibility and community engagement
- Strengths
Alkermes' strengths include its robust R&D pipeline, commitment to innovation in neuroscience, and a strong corporate culture dedicated to patient care and community impact.
- Positioning
Alkermes positions itself as a leader in the biopharmaceutical industry, focusing on neuroscience and the development of innovative treatments for complex disorders.
- Audience
The target users include patients with psychiatric and neurological disorders, healthcare providers, and investors interested in innovative biopharmaceutical solutions.
- CTA
Join Our Team
- Tags
Neuroscience
Innovative Medicines
Psychiatric Disorders
Corporate Responsibility
- Tagline
Great Science, Deep Compassion, Real Impact
- Tone of Voice
Compassionate, innovative, dedicated
- Differentiation
Alkermes stands out in the biopharmaceutical market through its deep neuroscience expertise and commitment to developing investigational medicines that address unmet medical needs in challenging disease areas.
- Brand Positioning
Alkermes identifies itself as a compassionate and innovative biopharmaceutical company dedicated to making a real impact on patients' lives through its medicines.
- Founded
1987-01-01
- Founders
Floyd Bloom
John Clarke
Paul Schimmel